Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-08-29

FDA Approved: PIMECROLIMUS — Original Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approved the original application for PIMECROLIMUS from Glenmark Pharmaceuticals Inc., USA for topical use in atopic dermatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pimecrolimus (pimecrolimus)

Snippet

ORIG AP for PIMECROLIMUS (PIMECROLIMUS)